INBX — Inhibrx Biosciences Inc. price, chart and key statistics

Price data

Price

$95.30

YTD price return

+20.63%

YTD total return

+20.63%

Next earnings

Nov 13, 2026

Market cap

1.4B2024-03 1.7B2026-10 1.4B-15.3% over the window

Enterprise value

1.5B

Shares outstanding

14.7M2023-12 47.4M2026-06 14.7M-68.9% over the window

52W low

$28.16

52W high

$155.29

From 52W high

-38.63%

From 52W low

+238.42%

52W range

53%

Volume

Rel volume

0.85×

30D volume

257.7K

30D $ vol

26.1M

Fundamentals

EPS (ttm)

-$8.882023-12 -$20.482026-06 -$8.88-56.7% over the window

FCF (ttm)

-131.9M2023-12 -197.9M2026-06 -131.9M-33.4% over the window

FCF/share

-$8.962023-12 -$4.182026-06 -$8.96+114.5% over the window

Book value/share

-$3.602023-12 $0.922026-06 -$3.60-491.9% over the window

ROA

-89.60%2023-12 -78.4%2026-06 -89.6%+14.3% over the window

Current ratio

5.072023-12 5.252026-06 5.07-3.4% over the window

Growth (CAGR, ttm) · 10Y

Shares

+1.60%2025-06-30 → 2026-06-3014.5M → 14.7M (+1.6% total)-37.38%2023-12-31 → 2026-06-3047.4M → 14.7M (-68.9% total)n/an/a

Per-share growth (CAGR, ttm) · 10Y

Price

+149.50%2025-10-20 → 2026-10-20$38.22 → $95.30 (+149.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+82.66%2023-10-20 → 2026-10-20$15.63 → $95.30 (+509.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+19.90%2021-10-20 → 2026-10-20$38.46 → $95.30 (+147.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

+149.50%2025-10-20 → 2026-10-20$38.22 → $95.30 (+149.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+82.66%2023-10-20 → 2026-10-20$15.63 → $95.30 (+509.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+19.90%2021-10-20 → 2026-10-20$38.46 → $95.30 (+147.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-10.7×2024-03 -6.862026-10 -10.15+47.9% over the window

Fwd P/E

-10.2×

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

-26.5×2024-03 38.072026-10 -26.48-169.5% over the window

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-9.40%2023-12 -12.0%2026-06 -9.5%-20.9% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 14.7M ÷ 14.5M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-1.60%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-1.60%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($206.7M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-1.60%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.4B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2023-12 0.0%2026-06 0.0%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.4B). Same caveat as the cash buyback yield.

0.00%2023-12 0.0%2026-06 0.0%